tiprankstipranks
Anbio Biotechnology Class A (NNNN)
NASDAQ:NNNN
US Market
NNNN
Anbio Biotechnology Class A
RESEARCH TOOLSreports
Want to see NNNN full AI Analyst Report?

Anbio Biotechnology Class A (NNNN) Revenue

60 Followers
StatisticsMarket CapRevenue

Anbio Biotechnology Class A Revenue

Anbio Biotechnology Class A had a revenue of 2.53M in the quarter ending Dec 31, 2024, with -60.01%. This bring the company's revenue in the last twelve months to 8.85M, Increased -13.85%. In the fiscal year ending Dec 31, 2025, Anbio Biotechnology Class A had annual revenue of 9.76M with 19.22% growth.
Revenue (ttm)
8.85M
Revenue Growth
10.10%
P/S Ratio
479.51
Revenue/Employee
$361,431
Employees
27
Market Cap
$4.68B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
9.76M1.57M+19.22%
Dec 31, 2024
8.19M1.47M+21.95%
Dec 31, 2023
6.71M-16.83M-71.49%
Dec 31, 2022
23.54M19.12M+431.67%
Dec 31, 2021
4.43M――